SMYD3 and cancer: Computational analysis of publicly available gene-expression data revealed that SMYD3 is particularly highly expressed in neuroendocrine lung cancer subtypes [SCLC and large cell neuroendocrine lung cancer (LCNE)] compared with other cancer subtypes and normal lung epithelium (Fig. 1B).